Virax Biolabs Completes UK Study Recruitment and Receives Positive FDA Feedback on ViraxImmune™ Assay Virax Biolabs Group has completed UK recruitment for its clinical study on the ViraxImmune™ assay, evaluating T cell dysfunction. Positive FDA feedback supports future development.

Virax Biolabs Completes UK Study Recruitment and Receives Positive FDA Feedback on ViraxImmune™ Assay #無し #Virax_Biolabs #T_cell_dysfunction #ViraxImmune

Virax Biolabs Initiates Clinical Study on T Cell Dysfunction for Post-acute Infections Virax Biolabs has begun enrolling patients for a clinical study investigating T cell dysfunction in post-acute infection syndromes, including long COVID.

Virax Biolabs Initiates Clinical Study on T Cell Dysfunction for Post-acute Infections #London #United_Kingdom #Virax_Biolabs #Long_COVID #T_cell_dysfunction

Virax Biolabs to Showcase Innovations at 19th World Immune Regulation Meeting in Davos Virax Biolabs will present groundbreaking findings on T cell dysfunction at the upcoming World Immune Regulation Meeting in Davos, Switzerland.

Virax Biolabs to Showcase Innovations at 19th World Immune Regulation Meeting in Davos #United_Kingdom #Virax_Biolabs #Davos #T_cell_dysfunction #immune_regulation